日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Isocitrate Dehydrogenase-Mutant Astrocytomas: Risk Stratification and Therapeutic Advance

异柠檬酸脱氢酶突变型星形细胞瘤:风险分层和治疗进展

Wei, Shepeng; Xu, Xuxu; Bao, Jing; Pan, Zhenjiang

Case Report: Meningioma with unusual extracranial extension to the temple and orbit

病例报告:脑膜瘤伴罕见的颅外延伸至颞部和眼眶。

Bao, Jing; Xu, Xuxu; Pan, Zhenjiang; Wei, Shepeng

Molecular convergence enables precision medicine for pediatric low grade gliomas

分子融合技术助力儿童低级别胶质瘤精准治疗

Xu, Xuxu; Bao, Jing; Wei, Shepeng; Pan, Zhenjiang

Advancing medulloblastoma therapy: strategies and survival insights

推进髓母细胞瘤治疗:策略和生存启示

Pan, Zhenjiang; Bao, Jing; Wei, Shepeng

Optimizing outcomes in intracranial ependymoma: a contemporary review

优化颅内室管膜瘤的治疗效果:最新综述

Pan, Zhenjiang; Bao, Jing; Wei, Shepeng

Vorasidenib for IDH-mutant grade 2 gliomas: clinical advances and future directions

Vorasidenib治疗IDH突变型2级胶质瘤:临床进展与未来方向

Pan, Zhenjiang; Bao, Jing; Wei, Shepeng

Tailored radiotherapy for brain metastases improves precision and outcomes

针对脑转移瘤的个体化放射治疗可提高治疗精准度和疗效。

Bao, Jing; Xu, Xuxu; Wei, Shepeng; Pan, Zhenjiang

Unlocking new horizons: advances in treating IDH-mutant, 1p/19q-codeleted oligodendrogliomas

开启新篇章:IDH突变型、1p/19q共缺失型少突胶质瘤治疗进展

Bao, Jing; Pan, Zhenjiang; Wei, Shepeng

A de novo meningioma with rapid growth: A possible malignancy imposter?

快速生长的新生脑膜瘤:可能是恶性肿瘤的伪装者?

Pan, Zhenjiang; Bao, Jing; Wei, Shepeng

Current chemotherapy strategies for adults with IDH-wildtype glioblastoma

目前针对IDH野生型胶质母细胞瘤成人患者的化疗策略

Bao, Jing; Sun, Rui; Pan, Zhenjiang; Wei, Shepeng